Reported Sep 21, 2022 · Terminated
Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10…
Pine Pharmaceuticals, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Pine Pharmaceuticals, LLC · 355 Riverwalk Pkwy · Tonawanda, NY · 14150-5837
Is this the product you have?
3 of 3 products
| Model / number | Product as published |
|---|---|
| — | Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection |
803 | packaged in a) 10 mL prefilled syringe, , barcode 6919408031 |
933 | 5 mL prefilled syringe, , barcode 6919409331, Rx only, Pine Pharmaceuticals, 355 Riverwalk Parkway, Tonawanda, NY 14150. |
- Lot codes and dates
Lot #s: a) 58366exp. date 09/26/202260247exp. date 12/04/2022b) 54825exp. date 08/10/202257583exp. date 08/22/202259343exp. date 10/30/202260355exp. date 10/11/2022
- Amount recalled
- a) 920 syringes; b) 3263 syringes
Where it was sold
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Pine Pharmaceuticals, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.